Motion text
That this House recognises that cervical cancer is preventable in over 99 per cent of cases, and that measures, including the HPV vaccine and cervical screenings, are key to its prevention; recognises that attending cervical screenings is crucial, and there are opportunities to improve the experience for both clinicians and patients through new, innovative technologies and approaches, including digital cytology; highlights NHS Monkland’s pioneering use of digital cytology, developed by the medical technology company, Hologic, which supports a more flexible and efficient cervical cancer screening programme; and encourages the wider adoption of digital cytology by NHS trusts throughout the UK to impact the effectiveness of cervical cancer screening.
Signatures (11)
The first 6 Members who have signed to support the motion are the sponsors. The primary sponsor is generally the person who tabled the motion and has responsibility for it. The date shown is when the Member signed the motion.
Cameron, Dr Lisa
Scottish National Party
Signed on
15 March 2022
Dorans, Allan
Scottish National Party
Signed on
16 March 2022
Shannon, Jim
Democratic Unionist Party
Signed on
16 March 2022
McDonnell, John
Labour
Signed on
16 March 2022
Jardine, Christine
Liberal Democrat
Signed on
17 March 2022
Maskell, Rachael
Labour
Signed on
21 March 2022
In addition to the sponsors, the following Members have signed to support the motion.
There are no withdrawn signatures for this motion.